These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 2258614

  • 1. Lipopolysaccharide-induced modulation of human monocyte urokinase production and activity.
    Manchanda N, Schwartz BS.
    J Immunol; 1990 Dec 15; 145(12):4174-80. PubMed ID: 2258614
    [Abstract] [Full Text] [Related]

  • 2. The THP-1 cell line is a urokinase-secreting mononuclear phagocyte with a novel defect in the production of plasminogen activator inhibitor-2.
    Gross TJ, Sitrin RG.
    J Immunol; 1990 Mar 01; 144(5):1873-9. PubMed ID: 2307845
    [Abstract] [Full Text] [Related]

  • 3. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.
    Gyetko MR, Webb AC, Sitrin RG.
    J Immunol; 1988 Oct 15; 141(8):2693-8. PubMed ID: 3139763
    [Abstract] [Full Text] [Related]

  • 4. Matrix-bound plasminogen activator inhibitor type 1 inhibits the invasion of human monocytes into interstitial tissue.
    Kirchheimer JC, Binder BR, Remold HG.
    J Immunol; 1990 Sep 01; 145(5):1518-22. PubMed ID: 1696600
    [Abstract] [Full Text] [Related]

  • 5. Endogenous receptor-bound urokinase mediates tissue invasion of human monocytes.
    Kirchheimer JC, Remold HG.
    J Immunol; 1989 Oct 15; 143(8):2634-9. PubMed ID: 2551965
    [Abstract] [Full Text] [Related]

  • 6. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
    Alitalo R, Andersson LC, Tapiovaara H, Sistonen L, Vaheri A, Stephens R.
    J Cell Physiol; 1989 Jul 15; 140(1):119-30. PubMed ID: 2500450
    [Abstract] [Full Text] [Related]

  • 7. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
    Margheri F, D'Alessio S, Serratì S, Pucci M, Del Rosso A, Benelli R, Ferrari N, Noonan DM, Albini A, Fibbi G, Del Rosso M.
    Int J Oncol; 2005 Jul 15; 27(1):223-35. PubMed ID: 15942664
    [Abstract] [Full Text] [Related]

  • 8. Regulation of plasminogen activator activity in arthritic joints.
    Hamilton JA, Hart PH, Leizer T, Vitti GF, Campbell IK.
    J Rheumatol Suppl; 1991 Feb 15; 27():106-9. PubMed ID: 1902874
    [Abstract] [Full Text] [Related]

  • 9. Urokinase-type plasminogen activator and its inhibitor secreted by cultured human monocyte-macrophages.
    Saksela O, Hovi T, Vaheri A.
    J Cell Physiol; 1985 Jan 15; 122(1):125-32. PubMed ID: 2578131
    [Abstract] [Full Text] [Related]

  • 10. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.
    Tabengwa EM, Grenett HE, Benza RL, Abou-Agag LH, Tresnak JK, Wheeler CG, Booyse FM.
    Alcohol Clin Exp Res; 2001 Feb 15; 25(2):163-70. PubMed ID: 11236828
    [Abstract] [Full Text] [Related]

  • 11. Cultured human mesangial cells produce both type 1 and type 2 plasminogen activator inhibitors.
    Colucci M, Gesualdo L, Montemurro P, Cavallo LG, Conese M, Mascolo E, Ranieri E, Di Paolo S, Schena FP, Semeraro N.
    Thromb Haemost; 1995 Dec 15; 74(6):1516-20. PubMed ID: 8772230
    [Abstract] [Full Text] [Related]

  • 12. Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells.
    Fukao H, Hagiya Y, Ueshima S, Okada K, Takaishi T, Izaki S, Matsuo O.
    Thromb Haemost; 1996 Feb 15; 75(2):352-8. PubMed ID: 8815589
    [Abstract] [Full Text] [Related]

  • 13. Presence of urokinase in serum-free primary rat hepatocyte cultures and its role in activating hepatocyte growth factor.
    Mars WM, Kim TH, Stolz DB, Liu ML, Michalopoulos GK.
    Cancer Res; 1996 Jun 15; 56(12):2837-43. PubMed ID: 8665523
    [Abstract] [Full Text] [Related]

  • 14. Glucocorticoid modulation of plasminogen activators and of one of their inhibitors in the human mammary carcinoma cell line MDA-MB-231.
    Busso N, Belin D, Failly-Crépin C, Vassalli JD.
    Cancer Res; 1987 Jan 15; 47(2):364-70. PubMed ID: 3098408
    [Abstract] [Full Text] [Related]

  • 15. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
    Allan EH, Martin TJ.
    J Cell Physiol; 1995 Dec 15; 165(3):521-9. PubMed ID: 7593231
    [Abstract] [Full Text] [Related]

  • 16. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF, de Vries C, Hohmann C, Veerman H, Pannekoek H.
    J Clin Invest; 1989 Aug 15; 84(2):647-55. PubMed ID: 2503541
    [Abstract] [Full Text] [Related]

  • 17. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W, Beck KF, Pfeilschifter J, Koch F, Hattenbach LO.
    Invest Ophthalmol Vis Sci; 2002 Aug 15; 43(8):2799-805. PubMed ID: 12147618
    [Abstract] [Full Text] [Related]

  • 18. Detection of both type 1 and type 2 plasminogen activator inhibitors in human monocytes.
    Castellote JC, Grau E, Linde MA, Pujol-Moix N, Rutllant ML.
    Thromb Haemost; 1990 Feb 19; 63(1):67-71. PubMed ID: 2339362
    [Abstract] [Full Text] [Related]

  • 19. Pro- and antifibrinolytic properties of human pulmonary microvascular versus artery endothelial cells: impact of endotoxin and tumor necrosis factor-alpha.
    Muth H, Maus U, Wygrecka M, Lohmeyer J, Grimminger F, Seeger W, Günther A.
    Crit Care Med; 2004 Jan 19; 32(1):217-26. PubMed ID: 14707582
    [Abstract] [Full Text] [Related]

  • 20. Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor.
    Fibbi G, Caldini R, Chevanne M, Pucci M, Schiavone N, Morbidelli L, Parenti A, Granger HJ, Del Rosso M, Ziche M.
    Lab Invest; 1998 Sep 19; 78(9):1109-19. PubMed ID: 9759655
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.